Delivery Order SPE2DB22D3301-SPE2DB25FY3MF
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,145.15 firm fixed-price delivery order is for the supply of 4,568,231,618 tablets of the medication Briviact 50 mg. The contract has an ultimate completion date of May 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,709.29, is for the delivery of 4,567,958,222 units of the prescription medication Briviact 100 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $2,814.41 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,160,678 units of the medication Briviact 50 mg tablets, with a completion date of May 7, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $3,036.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Briviact 100 mg tablets, a neurological medication, with a performance period through April 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $1,705.28 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Briviact 100 mg tablets. The contract has an ultimate completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,019.89, is for the delivery of Briviact 75 mg tablets to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 50 mg tablets. The contract has a ceiling value of $4,281.65 and an ultimate completion date of August 1, 2024. It is a firm-fixed-price delivery order contract, which means Amerisourcebergen will provide the specified pharmaceutical product at a pre-determined price. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.76 Firm Fixed Price Delivery Order is for the supply of 4,567,828,813 units of the prescription medication BRIVIACT 100 MG TABLET 60S. The contract has an ultimate completion date of April 8, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,068.67, is a delivery order for the medication Briviact 100 mg tablet. It is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,671.40 firm fixed-price contract is for the delivery of the drug Briviact in 100 mg tablet form, with a period of performance through April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...